# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-003401
Filing Date
2015-05-08
Accepted
2015-05-08 16:06:17
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0315_actiniumpharma.htm | 10-Q | 523957
2 | AGREEMENT | f10q0315ex10i_actinium.htm | EX-10.1 | 23921
3 | CERTIFICATION | f10q0315ex31i_actinium.htm | EX-31.1 | 14479
4 | CERTIFICATION | f10q0315ex32i_actinium.htm | EX-32.1 | 7656
| Complete submission text file | 0001213900-15-003401.txt |  | 4565462

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | atnm-20150331.xml | EX-101.INS | 540217
6 | XBRL SCHEMA FILE | atnm-20150331.xsd | EX-101.SCH | 46668
7 | XBRL CALCULATION FILE | atnm-20150331_cal.xml | EX-101.CAL | 22706
8 | XBRL DEFINITION FILE | atnm-20150331_def.xml | EX-101.DEF | 154006
9 | XBRL LABEL FILE | atnm-20150331_lab.xml | EX-101.LAB | 399417
10 | XBRL PRESENTATION FILE | atnm-20150331_pre.xml | EX-101.PRE | 257233

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 15846714
SIC: 2834 Pharmaceutical Preparations